Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aemetis (AMTX)
NASDAQ:AMTX
Aemetis (AMTX) Stock Price & Analysis
994 Followers
AMTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.75 - $8.99
Previous Close$2.97
Volume642.17K
Average Volume (3M)674.74K
Market Cap
$131.86M
Enterprise Value$426.10M
Total Cash (Recent Filing)$2.67M
Total Debt (Recent Filing)$296.91M
Price to Earnings (P/E)―
Beta3.50
Next Earnings
Aug 08, 2024EPS Estimate
-$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.11
Shares Outstanding44,397,833
10 Day Avg. Volume437,603
30 Day Avg. Volume674,737
Standard Deviation0.44
R-Squared0.02
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-0.58
Price to Sales (P/S)1.90
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.30
Enterprise Value/Gross Profit211.26
Enterprise Value/Ebitda-6.12
Forecast
1Y Price Target
$13.75Price Target Upside337.90% Upside
Rating ConsensusHold
Number of Analyst Covering4
Aemetis News
Bulls Say, Bears Say
Bulls Say
Financial StrategyAemetis is on track with its ambitious financial plan, aiming to achieve $1 billion in revenue, indicating a solid strategic direction and potential for substantial growth.
Market OpportunityAnalysts recognize the company's attractive valuation and recommend buying, seeing a significant upside potential based on current market prices and future financial projections.
Revenue GrowthThe company's India business is showing robust growth, with revenues climbing significantly, reflecting a strong upward trajectory in its market expansion.
Bears Say
Earnings ForecastAnalysts have reduced revenue estimates for the year, indicating potential challenges in the company's growth trajectory.
Earnings ForecastThe company's earnings per share (EPS) estimates have been revised downwards, suggesting a decrease in profitability.
Operational RisksThe company faces significant risks including dilution, dependence on a few key customers and suppliers, and regulatory challenges that could adversely affect its performance.
---
Ownership Overview
49.16% Insiders
9.00% Mutual Funds
16.44% Other Institutional Investors
25.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMTX FAQ
What was Aemetis’s price range in the past 12 months?
Aemetis lowest stock price was $2.75 and its highest was $8.99 in the past 12 months.
What is Aemetis’s market cap?
Currently, no data Available
When is Aemetis’s upcoming earnings report date?
Aemetis’s upcoming earnings report date is Aug 08, 2024 which is in 35 days.
How were Aemetis’s earnings last quarter?
Aemetis released its earnings results on May 09, 2024. The company reported -$0.58 earnings per share for the quarter, missing the consensus estimate of -$0.46 by -$0.12.
Is Aemetis overvalued?
According to Wall Street analysts Aemetis’s price is currently Undervalued.
Does Aemetis pay dividends?
Aemetis does not currently pay dividends.
What is Aemetis’s EPS estimate?
Aemetis’s EPS estimate is -$0.38.
How many shares outstanding does Aemetis have?
Aemetis has 44,397,835 shares outstanding.
What happened to Aemetis’s price movement after its last earnings report?
Aemetis reported an EPS of -$0.58 in its last earnings report, missing expectations of -$0.46. Following the earnings report the stock price went down -0.725%.
Which hedge fund is a major shareholder of Aemetis?
Among the largest hedge funds holding Aemetis’s share is GoalVest Advisory LLC. It holds Aemetis’s shares valued at 23K.
---
Aemetis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.75 (337.90% Upside)
$13.75 (337.90% Upside)
Blogger Sentiment
Bullish
AMTX Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $180.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.48%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.14%
Trailing 12-Months
Company Description
Aemetis
Aemetis, Inc. operates as a renewable fuels and biochemicals company. The firm focuses on the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into biorefineries. It operates through the North America and India segments. The North America segment comprises of the Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, the Goodland Plant, and the research and development facility in Minnesota. The India segment includes the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2005 and is headquartered in Cupertino, CA.
---
AMTX Earnings Call
Q1 2024
0:00 / 0:00
---
AMTX Stock 12 Month Forecast
Average Price Target
$13.75
▲(337.90% Upside)
Technical Analysis
Best Analysts Covering AMTX
1 Year
1 Year Success Rate
4/15 ratings generated profit
1 Year Average Return
-17.11%
reiterated a buy rating 4 months ago
Copying Derrick Whitfield's trades and holding each position for 1 Year would result in 26.67% of your transactions generating a profit, with an average return of -17.11% per trade.
---